Amcor plc · AMCR · FY2026 Q1 · Calendar Q4 2025

Amcor starts FY26 with synergy progress and maintained guidance

The quarter supports a constructive operating thesis built on acquisition synergies, portfolio optimization and resilient focus-category demand, but the evidence is not uniform: volume declines in Europe and the non-core North American beverage business remain important counterweights.

Reported After market closeNYSEConsumer Cyclical $19.79B market cap
90quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.95 Consensus $0.93
EPS surprise +2.7% Reported versus consensus
Reported revenue $5.75B Consensus $5.75B
Revenue surprise -0.1% Reported versus consensus

Market reaction

event-close to next-session close
Stock move +1.9% Event window
SPY move -1.1% Same window
Abnormal move +2.9% Stock minus SPY
Volume 1.6× Versus trailing sessions
Subsequent drift +1.0% Up to 20 sessions
AMCRSPY benchmark

Ask FN2 about AMCR FY2026 Q1

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Management highlighted $38 million of quarterly synergies, progress toward portfolio divestitures and continued cross-selling initiatives. The company maintained FY26 EPS guidance and reaffirmed free-cash-flow guidance, while adding detail on its longer-term synergy target and CFO transition.

Guidance delta

Management maintained FY26 EPS guidance and reaffirmed FY26 free-cash-flow guidance of $1.8–$1.9 billion.

Key takeaways

  • Management described a strong first quarter as a combined company, with adjusted EPS up 18% year over year and above the guidance midpoint.
  • The company delivered $38 million of synergies in the quarter and remains on track for its FY26 synergy target.
  • Portfolio optimization and growth initiatives remain central, while European and North American beverage volumes are areas to monitor.

Management priorities

  • Integrate the Berry acquisition and capture additional cost, G&A and procurement synergies.
  • Advance portfolio optimization, including planned divestitures of non-core businesses.
  • Pursue cross-selling and revenue synergies in health care, beauty, wellness, Asia-Pacific and Latin America.

Follow AMCR with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
AMCR EPS earnings history estimate and actual scatter chart 8 reported fiscal quarters and 4 future estimate-only quarters. Q2 '24 estimate $0.15 Q2 '24 actual $0.16, match Q3 '24 estimate $0.16 Q3 '24 actual $0.18, beat Q4 '24 estimate $0.20 Q4 '24 actual $0.21, match Q1 '25 estimate $0.16 Q1 '25 actual $0.16, match Q4 '25 estimate $0.21 Q4 '25 actual $1.00, beat Q1 '26 estimate $0.93 Q1 '26 actual $0.95, beat Q2 '26 estimate $0.83 Q2 '26 actual $0.86, beat Q4 '26 estimate $1.19 Q4 '26 actual $1.23, beat Q1 '27 estimate $1.07 Q2 '27 estimate $1.21 Q3 '27 estimate $1.09 Q4 '27 estimate $1.09

Analyst Consensus ?

ConsensusHold14 ratings
Bullish857.1%
Neutral535.7%
Bearish17.2%

Analyst 52W Price Targets

$42.11Current
$43Low
$52.78Average
$82.5High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 24, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
JP Morgan Neutral OverweightDowngradeAug 17, 2026
Wells Fargo Equal Weight Equal WeightMaintainAug 14, 2026
Citigroup Buy BuyMaintainAug 14, 2026
Jefferies Hold BuyDowngradeJul 22, 2026
BMO Capital Market Perform OutperformDowngradeJul 17, 2026
Show 9 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $42.11. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Truist FinancialMichael Roxland$51$46.2 +21.1%Aug 18, 2026
UBSNathan Reilly$56$47.11 +33.0%Aug 11, 2026
JefferiesRamoun Lazar$44.92$43.44 +6.7%Jul 21, 2026
BMO CapitalAnalyst unavailable$47$44.84 +11.6%Jul 16, 2026
Wells FargoAnalyst unavailable$43$42.78 +2.1%Jul 15, 2026
See 14 more

Track every rating change on AMCR the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Amcor plc stands as a prominent global provider of packaging solutions, focusing on the creation, production, and distribution of its diverse product portfolio across Europe, North America, Latin America, Africa, and the Asia Pacific regions. The company's operations are divided into two main segments: Flexibles and Rigid Packaging. The Flexibles division specializes in offering advanced flexible and film packaging solutions, catering to a wide array of industries including food and beverages, medical and pharmaceutical sectors, fresh produce, snack foods, and personal care items.…

Historical context

All AMCR earnings

Consumer Cyclical peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the AMCR recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-09-24T16:20:54.645026+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-24T16:20:54.642316+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-24. For educational purposes only; not investment advice.